<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33880486</PMID><DateRevised><Year>2022</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>May</Month><Day>12</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Vaccination boosts protective responses and counters SARS-CoV-2-induced pathogenic memory B cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2021.04.11.21255153</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2021.04.11.21255153</ELocationID><Abstract><AbstractText>Much is to be learned about the interface between immune responses to SARS-CoV-2 infection and vaccination. We monitored immune responses specific to SARS-CoV-2 Spike Receptor-Binding-Domain (RBD) in convalescent individuals for eight months after infection diagnosis and following vaccination. Over time, neutralizing antibody responses, which are predominantly RBD specific, generally decreased, while RBD-specific memory B cells persisted. RBD-specific antibody and B cell responses to vaccination were more vigorous than those elicited by infection in the same subjects or by vaccination in infection-na&#xef;ve comparators. Notably, the frequencies of double negative B memory cells, which are dysfunctional and potentially pathogenic, increased in the convalescent subjects over time. Unexpectedly, this effect was reversed by vaccination. Our work identifies a novel aspect of immune dysfunction in mild/moderate COVID-19, supports the practice of offering SARS-CoV-2 vaccination regardless of infection history, and provides a potential mechanistic explanation for the vaccination-induced reduction of "Long-COVID" symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Mishra</LastName><ForeName>Pankaj Kumar</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bruiners</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ukey</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Datta</LastName><ForeName>Pratik</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onyuka</LastName><ForeName>Alberta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Global Tuberculosis Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Handler</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Global Tuberculosis Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Sabiha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honnen</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sukhwinder</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NJMS Flow Cytometry and Immunology Core Laboratory, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerrini</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Advanced Biotechnology and Medicine, School of Public Health, Rutgers University, Piscataway, NJ 08854.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dewald</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choudhary</LastName><ForeName>Alok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horton</LastName><ForeName>Daniel B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrett</LastName><ForeName>Emily S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Environmental and Occupational Health Sciences Institute, School of Public Health, Rutgers University, Piscataway, NJ 08854.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, School of Public Health, Rutgers University, Piscataway, NJ 08854.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, School of Public Health, Rutgers University, Piscataway, NJ 08854.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Stanley H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitzgerald-Bocarsly</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaser</LastName><ForeName>Martin J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Center for Advanced Biotechnology and Medicine, School of Public Health, Rutgers University, Piscataway, NJ 08854.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carson</LastName><ForeName>Jeffrey L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panettieri</LastName><ForeName>Reynold A</ForeName><Initials>RA</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Rutgers Institute for Translational Medicine &amp; Science, New Brunswick, NJ 08901.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lardizabal</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Global Tuberculosis Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Theresa Li-Yun</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinter</LastName><ForeName>Abraham</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gennaro</LastName><ForeName>Maria Laura</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 AI122285</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 ES005022</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI152157</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003017</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL149450</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33880486</ArticleId><ArticleId IdType="pmc">PMC8057254</ArticleId><ArticleId IdType="doi">10.1101/2021.04.11.21255153</ArticleId><ArticleId IdType="pii">2021.04.11.21255153</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Long Q.X., et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 26, 845&#x2013;848 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32350462</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbiani D.F., et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584, 437&#x2013;442 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442695</ArticleId><ArticleId IdType="pubmed">32555388</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanat F., et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med 26, 1033&#x2013;1036 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8183627</ArticleId><ArticleId IdType="pubmed">32398876</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami A., et al. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis. Clin Microbiol Infect 27, 331&#x2013;340 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7584920</ArticleId><ArticleId IdType="pubmed">33228974</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Xiong J., Bao L. &amp; Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 20, 398&#x2013;400 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128218</ArticleId><ArticleId IdType="pubmed">32113510</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson L.A., et al. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. N Engl J Med 383, 1920&#x2013;1931 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7377258</ArticleId><ArticleId IdType="pubmed">32663912</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack F.P., et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 383, 2603&#x2013;2615 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel R.R., et al. Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Na&#xef;ve and Recovered Individuals Following mRNA Vaccination. medRxiv (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158969</ArticleId><ArticleId IdType="pubmed">33858945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8503938</ArticleId><ArticleId IdType="pubmed">33567448</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamatatos L., et al. mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection. Science (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8139425</ArticleId><ArticleId IdType="pubmed">33766944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D., et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260&#x2013;1263 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol 3, 237&#x2013;261 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5457962</ArticleId><ArticleId IdType="pubmed">27578435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajnberg A., et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science 370, 1227&#x2013;1230 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810037</ArticleId><ArticleId IdType="pubmed">33115920</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaney A.J., et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe 29, 463&#x2013;476.e466 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869748</ArticleId><ArticleId IdType="pubmed">33592168</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto D., et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32422645</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreano E., et al. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell 184, 1821&#x2013;1835.e1816 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7901298</ArticleId><ArticleId IdType="pubmed">33667349</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz L.M. (A Little) Clarity on Convalescent Plasma for Covid-19. N Engl J Med 384, 666&#x2013;668 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7821982</ArticleId><ArticleId IdType="pubmed">33440086</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a M., et al. Massive plasmablast response elicited in the acute phase of hantavirus pulmonary syndrome. Immunology 151, 122&#x2013;135 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5382343</ArticleId><ArticleId IdType="pubmed">28106253</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S., et al. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia. Eur J Immunol 50, 1283&#x2013;1294 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32910469</ArticleId></ArticleIdList></Reference><Reference><Citation>Buffa S., et al. B cell immunosenescence: different features of naive and memory B cells in elderly. Biogerontology 12, 473&#x2013;483 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21879287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruschil C., et al. Specific induction of double negative B cells during protective and pathogenic immune responses. bioRxiv, 2020.2009.2008.285148 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7775384</ArticleId><ArticleId IdType="pubmed">33391273</ArticleId></ArticleIdList></Reference><Reference><Citation>Moir S., et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205, 1797&#x2013;1805 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2525604</ArticleId><ArticleId IdType="pubmed">18625747</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard N.J. Double-negative B cells. Nat Rev Rheumatol 14, 684 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30367167</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenks S.A., et al. Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Immunity 49, 725&#x2013;739.e726 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6217820</ArticleId><ArticleId IdType="pubmed">30314758</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S., et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun 11, 3434 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7338513</ArticleId><ArticleId IdType="pubmed">32632085</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio C.R., et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell 183, 968&#x2013;981.e967 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370(2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., et al. Diverse Functional Autoantibodies in Patients with COVID-19. medRxiv (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederer K., et al. SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation. Immunity 53, 1281&#x2013;1295.e1285 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680029</ArticleId><ArticleId IdType="pubmed">33296685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko N., et al. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19. Cell 183, 143&#x2013;157.e113 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437499</ArticleId><ArticleId IdType="pubmed">32877699</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M.C., et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol 21, 1506&#x2013;1516 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7739702</ArticleId><ArticleId IdType="pubmed">33028979</ArticleId></ArticleIdList></Reference><Reference><Citation>  https://www.nytimes.com/2021/03/17/health/coronavirus-patients-and-vaccine-effects.html.</Citation></Reference><Reference><Citation>Barrett E.S., et al. Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemic. BMC Infect Dis 20, 853 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668027</ArticleId><ArticleId IdType="pubmed">33198725</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers T.F., et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science 369, 956&#x2013;963 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299280</ArticleId><ArticleId IdType="pubmed">32540903</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X., et al. An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe 27, 841&#x2013;848.e843 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153529</ArticleId><ArticleId IdType="pubmed">32289263</ArticleId></ArticleIdList></Reference><Reference><Citation>Case J.B., Bailey A.L., Kim A.S., Chen R.E. &amp; Diamond M.S. Growth, detection, quantification, and inactivation of SARS-CoV-2. Virology 548, 39&#x2013;48 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7293183</ArticleId><ArticleId IdType="pubmed">32838945</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrigucci R., et al. FISH-Flow, a protocol for the concurrent detection of mRNA and protein in single cells using fluorescence in situ hybridization and flow cytometry. Nat Protoc 12, 1245&#x2013;1260 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5548662</ArticleId><ArticleId IdType="pubmed">28518171</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>